Morning Breakouts

Latest KFF Health News Stories

With New Cancer Database, Biden Wants To Destroy Researcher ‘Cult Of The Individual’

Morning Briefing

Genomic Data Commons has launched with clinical data for 12,000 patients, with more to come. The project aims to bolster team science in a field that Vice President Joe Biden says tends toward researchers siloing themselves. In other news, a study finds that cancer patients are still being treated aggressively at the end of their lives.

Consumer Groups Seek Transparency In Missouri Review Of Aetna-Humana Merger

Morning Briefing

In other marketplace news, filings indicate that some of Connecticut’s major insurers will seek premium rate hikes above medical inflation, while in Ohio, a new insurance product could reduce premium costs by 15 percent.

John Oliver Forgives $15M In Medical Debt

Morning Briefing

The “Last Week Tonight” host’s latest stunt-with-a-message — to buy nearly $15 million in medical debt for just $60,000 — highlights the struggle many cope with after getting sick and amassing huge bills. And although the Affordable Care Act means more people have insurance to help pay for those sky-high costs, people are still leaving the hospital with crippling debt.

Senate’s Health Spending Bill Reportedly Will Bump Up NIH Funding By $2 Billion

Morning Briefing

A senate subcommittee is expected to get a markup bill today that will include the new NIH funding, as well as increases in spending on initiatives for Alzheimer’s disease, opioid abuse, precision medicine and antibiotic resistance. In other Capitol Hill news, the House is getting ready to act on a hospital bill and Speaker Paul Ryan is slated this week to release his action plan, which will include health measures.

Doing Too Much, Too Fast: The Lessons Clinton Learned From Hillarycare’s Failure

Morning Briefing

In 1993, Hillary Clinton pushed a grand sweeping plan to ensure all Americans had health insurance. She took her ideas to Capitol Hill, and what happened next was instrumental in shaping the presidential candidate’s approach to governing and politics.

Muhammad Ali And Parkinson’s: ‘He Can Speak To People With His Heart’

Morning Briefing

Muhammad Ali, who died on Friday, was diagnosed with Parkinson’s in 1984, a disease that eventually took away his motor skills and his ability to speak clearly. The boxer has been instrumental in raising awareness of the condition.

Deployment Of Crispr Gene Editing May Unlock Vast Potential To Target Viruses

Morning Briefing

Many viruses don’t contain DNA. Instead, their genetic information is encoded in RNA, which they use to hijack the genes of their hosts. If scientists can use gene editing to target that RNA instead, they could make advances in such areas as HIV and poliovirus. In other news, families that have a child with a rare genetic condition often struggle with isolation when coping with the diagnosis.

A Hot New Trend In Oncology: Blood Tests Over Invasive Biopsies

Morning Briefing

Researchers report that these “liquid tests” — which are less painful and risky — have proven to have results that agree with a tumor biopsy. In other news, a study shows that women who take an estrogen-suppressing drug for double the time lower their risk of their cancer returning; scientists say immunotherapy is untested in patients with autoimmune diseases; and a Minnesota cancer research center celebrates its expansion.

Cancer Researchers Weigh Benefit Of Three-Drug Combinations With Resulting Higher Costs

Morning Briefing

Combination regimens hold promise for patients but could heighten tensions over the escalating expense of cancer drugs. Meanwhile, Marketplace reports on a company that is cutting deals with pharmaceutical companies to try to rein those costs.

After Turmoil, Valeant Is Under Pressure To Show Return To Normalcy With Earnings

Morning Briefing

The drugmaker will report first quarter earnings Tuesday, and analysts will be looking to see how the company plans to resume generating profit and growth without the controversial moves it used to increase prices in the past. Other drug company news comes from Pfizer’s chief executive and Martin Shkreli, the former head of Retrophin and Turing, who faces an additional charge.